NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Litfulo Capsules Special Investigation

Active Not RecruitingN/A

Sponsor: Pfizer

Conditions: Alopecia Areata

Interventions: LITFULO

Countries: Japan

The objective of this Study is to confirm the safety during the long-term use of this drug and the effectiveness during the use of this drug under the actual use in the patients treated with this drug.

Eligibility overview

Sex: ALL

Age: 0 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

Patients must meet all of the following inclusion criteria to be eligible for inclusion in the study:

* Patients with alopecia areata who start receiving this drug for the first time after the contract date of this study
* Patients who have not participated in a clinical trial (clinical study) of this drug

Exclusion Criteria:

Patients meeting any of the following criteria will not be included in the study:

* Patients previously enrolled in this study
* Patients with a history of treatment with this drug (including investigational product)

Locations (1)

Tokyo, Japan